biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > True Story

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 24, 2023 7:12pm

132 Views

Post# 35243693

RE:RE:RE:RE:RE:RE:RE:RE:RE:True Story

Legacy, uncle? I'm destroy my legacy?

I don't write for when I'm dead. The Bioasis Stockhouse Bullboard will not go down in history as a great literary repository.

This is trench warfare. Verbal slugfests with little nuggets of value sprinkled here and there among the bombs.

Gosh. I didn't expect you to go all emotional and nostalgic about it.

jd

<< Previous

Bullboard Posts

Next >>

How Canadian investors can benefit from flow-through shares